News

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Sandoz launches Tyruko in U.S. as first and only MS biosimilar

noviembre 20, 2025

Tyruko approved for all indications of reference medicine Tysabri.
Learn more

Study suggests BTK inhibitor slows MS disability progression as effectively as Ocrevus

noviembre 12, 2025

Genentech’s fenebrutinib shows positive phase III results as the potential first BTK inhibitor in both relapsing and primary progressive MS.
Learn more

Study maps brain development and how it resolves inflammation

noviembre 06, 2025

Findings could offer insights into how MS develops and provide new tools for treating the disease.
Learn more

Study reveals the hidden burden of MS on quality of life

octubre 30, 2025

Findings highlight the need for healthcare services to recognize the effect of MS on wellbeing across all age groups.
Learn more

Study suggests MS harms a brain long before symptoms appear

octubre 23, 2025

Signaling protein may hold key to early diagnosis.
Learn more

Scientists claim X-chromosome gene linked to MS

octubre 22, 2025

Mouse study reveals how females' double X chromosomes drive brain inflammation and identifies diabetes drug as potential treatment.
Learn more

Study finds estrogen could aid in progressive MS therapies

octubre 21, 2025

Researchers studied the protective effects of estradiol and estriol on the myelin sheath.
Learn more

Inflammatory brain cells driving progressive MS are discovered

octubre 14, 2025

Findings provide promising new avenue for research into more effective therapies.
Learn more

Scientists identify two compounds that may help people with MS

octubre 10, 2025

Lead candidate promotes remyelination and modulates immune function, researchers claim.
Learn more

Sandoz launches Tyruko in U.S. as first and only MS biosimilar

noviembre 20, 2025

Tyruko approved for all indications of reference medicine Tysabri.
Learn more

Study suggests BTK inhibitor slows MS disability progression as effectively as Ocrevus

noviembre 12, 2025

Genentech’s fenebrutinib shows positive phase III results as the potential first BTK inhibitor in both relapsing and primary progressive MS.
Learn more

Study maps brain development and how it resolves inflammation

noviembre 06, 2025

Findings could offer insights into how MS develops and provide new tools for treating the disease.
Learn more

Study reveals the hidden burden of MS on quality of life

octubre 30, 2025

Findings highlight the need for healthcare services to recognize the effect of MS on wellbeing across all age groups.
Learn more

Study suggests MS harms a brain long before symptoms appear

octubre 23, 2025

Signaling protein may hold key to early diagnosis.
Learn more

Scientists claim X-chromosome gene linked to MS

octubre 22, 2025

Mouse study reveals how females' double X chromosomes drive brain inflammation and identifies diabetes drug as potential treatment.
Learn more

Study finds estrogen could aid in progressive MS therapies

octubre 21, 2025

Researchers studied the protective effects of estradiol and estriol on the myelin sheath.
Learn more

Inflammatory brain cells driving progressive MS are discovered

octubre 14, 2025

Findings provide promising new avenue for research into more effective therapies.
Learn more

Scientists identify two compounds that may help people with MS

octubre 10, 2025

Lead candidate promotes remyelination and modulates immune function, researchers claim.
Learn more

Brain myelin damage could lead to seizures in MS

octubre 09, 2025

Study may explain why some people living with MS experience epileptic seizures.
Learn more

Early symptoms of MS same across ethnic and social groups, a new study suggests

octubre 03, 2025

A better understanding of this phase across the entire population could aid in early diagnosis.
Learn more

Study suggests MS does not worsen menopause symptoms

octubre 01, 2025

Previous studies were small and produced conflicting results.
Learn more

AI analysis prompts international reassessment of MS

agosto 26, 2025

Model identifies four central state dimensions that better capture disease progression.
Learn more

DMT management crucial for therapeutic planning before pregnancy

agosto 11, 2025

A strategy based on the use of anti-CD20 before pregnancy may mitigate relapse risk.
Learn more

MS may begin earlier than previously thought

agosto 07, 2025

People with MS see higher healthcare use up to 15 years before symptoms appear.
Learn more

Women less likely than men to receive MS drugs

agosto 04, 2025

In the case of newer, highly effective medications, women had 20 percent lower odds of receiving them.
Learn more

Study suggests link between mitochondria, MS brain damage

junio 24, 2025

Findings could lead to new treatments addressing multiple sclerosis.
Learn more

Researchers find evidence of accelerated aging in children with MS

junio 16, 2025

First-of-its kind study reveals signs of premature biological aging in teenagers with MS pointing to new treatment possibilities beyond immunosuppression.
Learn more


Show More News